Global AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Regional Outlook and Forecast, 2022

List of Tables

The Global AI In Cancer Diagnostics Market size is expected to reach $509 million by 2028, rising at a market growth of 28.6% CAGR during the forecast period.

Artificial intelligence is an algorithm or computer program that utilizes data or information to make predictions and conclusions. To develop an algorithm, developers have created a bunch of rules or guidelines for the computer to follow the rules and commands. For an instant, Dr. Turkbey along with his team leveraged the current rules about prostate cancer that showed up on the MRI scan machine.

With the help of the machine crew utilized thousands of MRI research in their algorithm, which concluded many people has prostate cancer whereas many of them didn't have any signs of cancer. The algorithm enrolls in how to evaluate and understand data while utilizing machine learning or artificial intelligence. Machine learning may utilize data that are not visible to the human brain or eyes.

Moreover, these algorithms keep on updating and being informed as they are exposed to new data. Deep learning along with machine learning and AI in the detection of cancer. It also utilizes Artificial neural networks which replicate how the human brain collects, analyzes, and reacts to the signals from the entire body. Researchers in NCI's intramural research program is utilizing the complete abilities of AI to enhance cancer testing in prostate and cervical cancer.

15 years ago, NCI physicians started executing biopsies backed by Magnetic resonance imaging, allowing researchers to target the areas of the prostate which could be cancerous. MRI biopsy enhanced the detection and treatment performed by prostate cancer professionals. Moreover, AI helps clinicians to record their diagnostic skills as well as makes algorithms available for clinics across the nation to assist with clinical diagnostics and decision-making.

COVID - 19 Impact Analysis

The coronavirus had a positive impact on AI in the cancer diagnostic market. The implementation of the AI and machine learning assisted to reduce the workload of the health care and clinical facilities. With the growth of the industry, many international IT juggernauts have stepped with to develop AI tools and software to identify the coronavirus which would later help in detecting cancer symptoms. The shortage of healthcare professionals due to the coronavirus cases drives the adoption of AI solutions for better patient assistance and results. The diagnosis, aftercare, and other procedure were hard to maintain during the pandemic as they were time-consuming.

Market Growth Factors

Increasing technological advancements in the healthcare sector

The technologies and the adoption of artificial intelligence in the detection of cancer diagnostics propel the growth of the healthcare sector. The artificial tools contain the need for low-price diagnostic procedures and quick detection data generation. The demand for technology developments in the healthcare sector for detecting and screening cancer is also anticipated to support industry growth. Moreover, the technological enhancement in healthcare by government spending drives the growth of the health care sectors in emerging nations.

Growing need for early cancer diagnosis

The growing awareness of early cancer diagnostics drives the growth of AI in cancer diagnostics. The rise in the number of government programs to promote healthcare organizations along with healthcare providers to combine AI technologies in their hospitals for the betterment and advance the therapy of the patients. Moreover, the adoption of the technologies helps private organizations and nonprofit organizations to deliver enhanced medical results and the reduced cost of treatment which increases early diagnostic among people.

Market Restraining Factors

Lack of Understanding of AI Use in the Healthcare Sector

Managing huge datasets and databases along with the knowledge & training of AI systems and machine learning is the biggest barrier to deep learning technologies. However, the utilization of AI can also bring the issue of data breaches because it could provide crucial individual data such as genomic sequences. The various issues restricting the growth include the lack of transparency, risk of bias for the AI algorithms, data utilized for training purposes, and problem encounters while AI implementation authority in clinical settings. Philosophical issues are one of the thorniest problems faced in artificial intelligence.

End-User Outlook

By End-user, the AI in Cancer Diagnostics Market is classified into Hospital, Surgical Centers and Medical Institutes, and Others. The surgical centers & medical institutes segment registered a remarkable revenue share in the AI in cancer diagnostics market in 2021. It is because the adoption of AI has reduced the cases of misleading negatives and positives to deliver enhanced patient results. The evolution of medical education is propelling along with the growth of healthcare. Moreover, the adoption and practice of medicine with the implementation of AI and the utilization of data learning for better invention enhance the growth and decision making in the industry.

Component Outlook

Based on the Component, the AI in Cancer Diagnostics Market is segmented into Software Solutions Hardware, and Services. The software solutions segment acquired the highest revenue share in the AI in cancer diagnostics market in 2021. It is because many big competitors are launching new solutions for the diagnosis of cancer. With the help of the software, doctors can efficiently and precisely identify the micro size of cancer or tumor. Moreover, artificial intelligence software is more precise and trustworthy than the human diagnostic system. The software platform provides high-quality analytics, and quick results grow the confidence of the doctors as well as boost productivity along with human safety.

Cancer Type Outlook

On the basis of Cancer Type, the AI in Cancer Diagnostics Market is divided into Breast Cancer, Lung Cancer, Prostate & Colorectal Cancer, Brain Tumor, Skin Cancer & Cervical Cancer and Others. The breast cancer segment procured the largest revenue share in the AI in cancer diagnostics market in 2021. It is because the incidence of breast cancer is growing due to the cells in the breast growing out of control. Breast cancer depends on which cell is infected in the breast which came out as cancer. The breast is made up of three components which include ducts, lobules, and connective tissue.

Regional Outlook

Region-wise, the AI in Cancer Diagnostics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the AI in cancer diagnostics market in 2021. The growing cancer prevalence along with the accessibility of the updated healthcare infrastructure propel the growth of the market. However, the increasing government initiatives and the expenditure in the healthcare sector drive the growth of AI in the medical sector. The growing number of patient's diagnostic propels the growth of AI in cancer diagnostics in this region.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Microsoft Corporation is the forerunner in the AI In Cancer Diagnostics Market. Companies such as Flatiron Health (F. Hoffmann-La Roche Ltd.), Paige AI, Inc., PathAI, Inc. are some of the key innovators in AI In Cancer Diagnostics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Recent Strategies Deployed in AI In Cancer Diagnostics Market

Partnership, Collaboration and Agreement:

Nov-2022: Flatiron Health came into partnership with Caris Life Sciences (Caris), the leading molecular science and technology company. Through this partnership, the company aimed at broadening access to precision medicine at the point of care with seamless ordering and receipt of Caris molecular profiling by integrating OncoEMR platform, a leading cloud-based electronic medical record (EMR) tool.

Aug-2022: PathAI came into partnership with Bristol Myers Squibb, an American multinational pharmaceutical company. Through this partnership, the company aimed at developing drugs by expanding the use of artificial intelligence (AI).

Jan-2022: Flatiron Health joined hands with NCCHE, a Japanese cancer center that provides cancer medicine. The collaboration is aimed at expanding the company's international presence.

Nov-2021: Kheiron Medical Technologies teamed up with Stanford University, a private research university. This collaboration aimed at using the expertise of the Stanford Center for Artificial Intelligence in Medicine & Imaging to enhance the use of AI in new areas of Oncology.

Oct-2021: PathAI came into partnership with Roche, a biotechnology company that develops and provides drugs and diagnostics. Through this partnership, the company aimed at developing and providing its AI pathology through Roche's uPath enterprise software.

Jun-2021: Kheiron Medical Technologies entered into a partnership with Atlas Medical, a manufacturer and supplier of quality Diagnostic Reagents and Kits. The partnership is aimed at launching Mia, a solution for breast cancer screening that supports radiologists in detecting cancer more accurately.

May-2021: Paige joined hands with Quest Diagnostics, an American clinical laboratory that provides diagnostic insights. Through this collaboration, the company aimed at delivering faster, more accurate, and more informed clinical insights by creating new software.

Mar-2021: Paige came into partnership with Epredia, a global leader in precision cancer diagnostics. Through this partnership, the company aimed at helping pathologists to unlock insights from each sample and provide results to the patient and clinician more quickly by offering a portfolio of software.

Dec-2020: Tempus joined hands with Bayer, a German multinational pharmaceutical and biotechnology company. The collaboration aimed at providing genomic testing access and tailored treatment approaches for the oncology community.

Product Launch and Product Expansion:

May-2022: Therapixel launched MammoScreen - 2D and 3D, an AI-based software that automatically analyzes mammograms and displays a summary report to radiologists, providing breast cancer detection and using prior exams to refine prediction.

Mar-2022: Paige unveiled Paige Breast Lymph Node, an AI medical device software, designed to increase the accuracy and efficiency in the detection of breast cancer. The launch focused on helping pathologists detecting if breast cancer has metastasized to lymph nodes.

Acquisition, Joint Venture and Merger:

Jul-2021: PathAI completed the acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider. Through this acquisition, the company would be able to integrate testing services into its existing artificial intelligence-powered pathology platform.

Scope of the Study

Market Segments covered in the Report:

By End-user

Hospital
Surgical Centers & Medical Institutes
Others

By Component

Software Solutions
Hardware
Services

By Cancer Type

Breast Cancer
Lung Cancer
Brain Tumor
Skin Cancer & Cervical Cancer
Prostate & Colorectal Cancer
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Microsoft Corporation
Flatiron Health
Paige AI, Inc.
PathAI, Inc.
Therapixel
Tempus, Inc.
SkinVision BV
Cancer Center Sp. z o.o.
Medial EarlySign
Kheiron Medical Technologies Limited

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global AI In Cancer Diagnostics Market, by End-user
- 1.4.2 Global AI In Cancer Diagnostics Market, by Component
- 1.4.3 Global AI In Cancer Diagnostics Market, by Cancer Type
- 1.4.4 Global AI In Cancer Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players

Chapter 4. Global AI In Cancer Diagnostics Market by End-user

4.1 Global Hospital Market by Region
4.2 Global Surgical Centers & Medical Institutes Market by Region
4.3 Global Others Market by Region

Chapter 5. Global AI In Cancer Diagnostics Market by Component

5.1 Global Software Solutions Market by Region
5.2 Global Hardware Market by Region
5.3 Global Services Market by Region

Chapter 6. Global AI In Cancer Diagnostics Market by Cancer Type

6.1 Global Breast Cancer Market by Region
6.2 Global Lung Cancer Market by Region
6.3 Global Brain Tumor Market by Region
6.4 Global Skin Cancer & Cervical Cancer Market by Region
6.5 Global Prostate & Colorectal Cancer Market by Region
6.6 Global Others Market by Region

Chapter 7. Global AI In Cancer Diagnostics Market by Region

7.1 North America AI In Cancer Diagnostics Market
- 7.1.1 North America AI In Cancer Diagnostics Market by End-user
  - 7.1.1.1 North America Hospital Market by Country
  - 7.1.1.2 North America Surgical Centers & Medical Institutes Market by Country
  - 7.1.1.3 North America Others Market by Country
- 7.1.2 North America AI In Cancer Diagnostics Market by Component
  - 7.1.2.1 North America Software Solutions Market by Country
  - 7.1.2.2 North America Hardware Market by Country
  - 7.1.2.3 North America Services Market by Country
- 7.1.3 North America AI In Cancer Diagnostics Market by Cancer Type
  - 7.1.3.1 North America Breast Cancer Market by Country
  - 7.1.3.2 North America Lung Cancer Market by Country
  - 7.1.3.3 North America Brain Tumor Market by Country
  - 7.1.3.4 North America Skin Cancer & Cervical Cancer Market by Country
  - 7.1.3.5 North America Prostate & Colorectal Cancer Market by Country
  - 7.1.3.6 North America Others Market by Country
- 7.1.4 North America AI In Cancer Diagnostics Market by Country
  - 7.1.4.1 US AI In Cancer Diagnostics Market
    - 7.1.4.1.1 US AI In Cancer Diagnostics Market by End-user
    - 7.1.4.1.2 US AI In Cancer Diagnostics Market by Component
    - 7.1.4.1.3 US AI In Cancer Diagnostics Market by Cancer Type
  - 7.1.4.2 Canada AI In Cancer Diagnostics Market
    - 7.1.4.2.1 Canada AI In Cancer Diagnostics Market by End-user
    - 7.1.4.2.2 Canada AI In Cancer Diagnostics Market by Component
    - 7.1.4.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
  - 7.1.4.3 Mexico AI In Cancer Diagnostics Market
    - 7.1.4.3.1 Mexico AI In Cancer Diagnostics Market by End-user
    - 7.1.4.3.2 Mexico AI In Cancer Diagnostics Market by Component
    - 7.1.4.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
  - 7.1.4.4 Rest of North America AI In Cancer Diagnostics Market
    - 7.1.4.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
    - 7.1.4.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
    - 7.1.4.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
7.2 Europe AI In Cancer Diagnostics Market
- 7.2.1 Europe AI In Cancer Diagnostics Market by End-user
  - 7.2.1.1 Europe Hospital Market by Country
  - 7.2.1.2 Europe Surgical Centers & Medical Institutes Market by Country
  - 7.2.1.3 Europe Others Market by Country
- 7.2.2 Europe AI In Cancer Diagnostics Market by Component
  - 7.2.2.1 Europe Software Solutions Market by Country
  - 7.2.2.2 Europe Hardware Market by Country
  - 7.2.2.3 Europe Services Market by Country
- 7.2.3 Europe AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.3.1 Europe Breast Cancer Market by Country
  - 7.2.3.2 Europe Lung Cancer Market by Country
  - 7.2.3.3 Europe Brain Tumor Market by Country
  - 7.2.3.4 Europe Skin Cancer & Cervical Cancer Market by Country
  - 7.2.3.5 Europe Prostate & Colorectal Cancer Market by Country
  - 7.2.3.6 Europe Others Market by Country
- 7.2.4 Europe AI In Cancer Diagnostics Market by Country
  - 7.2.4.1 Germany AI In Cancer Diagnostics Market
    - 7.2.4.1.1 Germany AI In Cancer Diagnostics Market by End-user
    - 7.2.4.1.2 Germany AI In Cancer Diagnostics Market by Component
    - 7.2.4.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.4.2 UK AI In Cancer Diagnostics Market
    - 7.2.4.2.1 UK AI In Cancer Diagnostics Market by End-user
    - 7.2.4.2.2 UK AI In Cancer Diagnostics Market by Component
    - 7.2.4.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.4.3 France AI In Cancer Diagnostics Market
    - 7.2.4.3.1 France AI In Cancer Diagnostics Market by End-user
    - 7.2.4.3.2 France AI In Cancer Diagnostics Market by Component
    - 7.2.4.3.3 France AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.4.4 Russia AI In Cancer Diagnostics Market
    - 7.2.4.4.1 Russia AI In Cancer Diagnostics Market by End-user
    - 7.2.4.4.2 Russia AI In Cancer Diagnostics Market by Component
    - 7.2.4.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.4.5 Spain AI In Cancer Diagnostics Market
    - 7.2.4.5.1 Spain AI In Cancer Diagnostics Market by End-user
    - 7.2.4.5.2 Spain AI In Cancer Diagnostics Market by Component
    - 7.2.4.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.4.6 Italy AI In Cancer Diagnostics Market
    - 7.2.4.6.1 Italy AI In Cancer Diagnostics Market by End-user
    - 7.2.4.6.2 Italy AI In Cancer Diagnostics Market by Component
    - 7.2.4.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
  - 7.2.4.7 Rest of Europe AI In Cancer Diagnostics Market
    - 7.2.4.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
    - 7.2.4.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
    - 7.2.4.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
7.3 Asia Pacific AI In Cancer Diagnostics Market
- 7.3.1 Asia Pacific AI In Cancer Diagnostics Market by End-user
  - 7.3.1.1 Asia Pacific Hospital Market by Country
  - 7.3.1.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
  - 7.3.1.3 Asia Pacific Others Market by Country
- 7.3.2 Asia Pacific AI In Cancer Diagnostics Market by Component
  - 7.3.2.1 Asia Pacific Software Solutions Market by Country
  - 7.3.2.2 Asia Pacific Hardware Market by Country
  - 7.3.2.3 Asia Pacific Services Market by Country
- 7.3.3 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.3.1 Asia Pacific Breast Cancer Market by Country
  - 7.3.3.2 Asia Pacific Lung Cancer Market by Country
  - 7.3.3.3 Asia Pacific Brain Tumor Market by Country
  - 7.3.3.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
  - 7.3.3.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
  - 7.3.3.6 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific AI In Cancer Diagnostics Market by Country
  - 7.3.4.1 China AI In Cancer Diagnostics Market
    - 7.3.4.1.1 China AI In Cancer Diagnostics Market by End-user
    - 7.3.4.1.2 China AI In Cancer Diagnostics Market by Component
    - 7.3.4.1.3 China AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.4.2 Japan AI In Cancer Diagnostics Market
    - 7.3.4.2.1 Japan AI In Cancer Diagnostics Market by End-user
    - 7.3.4.2.2 Japan AI In Cancer Diagnostics Market by Component
    - 7.3.4.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.4.3 India AI In Cancer Diagnostics Market
    - 7.3.4.3.1 India AI In Cancer Diagnostics Market by End-user
    - 7.3.4.3.2 India AI In Cancer Diagnostics Market by Component
    - 7.3.4.3.3 India AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.4.4 South Korea AI In Cancer Diagnostics Market
    - 7.3.4.4.1 South Korea AI In Cancer Diagnostics Market by End-user
    - 7.3.4.4.2 South Korea AI In Cancer Diagnostics Market by Component
    - 7.3.4.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.4.5 Singapore AI In Cancer Diagnostics Market
    - 7.3.4.5.1 Singapore AI In Cancer Diagnostics Market by End-user
    - 7.3.4.5.2 Singapore AI In Cancer Diagnostics Market by Component
    - 7.3.4.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.4.6 Malaysia AI In Cancer Diagnostics Market
    - 7.3.4.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
    - 7.3.4.6.2 Malaysia AI In Cancer Diagnostics Market by Component
    - 7.3.4.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
  - 7.3.4.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
    - 7.3.4.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
    - 7.3.4.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
    - 7.3.4.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
7.4 LAMEA AI In Cancer Diagnostics Market
- 7.4.1 LAMEA AI In Cancer Diagnostics Market by End-user
  - 7.4.1.1 LAMEA Hospital Market by Country
  - 7.4.1.2 LAMEA Surgical Centers & Medical Institutes Market by Country
  - 7.4.1.3 LAMEA Others Market by Country
- 7.4.2 LAMEA AI In Cancer Diagnostics Market by Component
  - 7.4.2.1 LAMEA Software Solutions Market by Country
  - 7.4.2.2 LAMEA Hardware Market by Country
  - 7.4.2.3 LAMEA Services Market by Country
- 7.4.3 LAMEA AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.3.1 LAMEA Breast Cancer Market by Country
  - 7.4.3.2 LAMEA Lung Cancer Market by Country
  - 7.4.3.3 LAMEA Brain Tumor Market by Country
  - 7.4.3.4 LAMEA Skin Cancer & Cervical Cancer Market by Country
  - 7.4.3.5 LAMEA Prostate & Colorectal Cancer Market by Country
  - 7.4.3.6 LAMEA Others Market by Country
- 7.4.4 LAMEA AI In Cancer Diagnostics Market by Country
  - 7.4.4.1 Brazil AI In Cancer Diagnostics Market
    - 7.4.4.1.1 Brazil AI In Cancer Diagnostics Market by End-user
    - 7.4.4.1.2 Brazil AI In Cancer Diagnostics Market by Component
    - 7.4.4.1.3 Brazil AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.4.2 Argentina AI In Cancer Diagnostics Market
    - 7.4.4.2.1 Argentina AI In Cancer Diagnostics Market by End-user
    - 7.4.4.2.2 Argentina AI In Cancer Diagnostics Market by Component
    - 7.4.4.2.3 Argentina AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.4.3 UAE AI In Cancer Diagnostics Market
    - 7.4.4.3.1 UAE AI In Cancer Diagnostics Market by End-user
    - 7.4.4.3.2 UAE AI In Cancer Diagnostics Market by Component
    - 7.4.4.3.3 UAE AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.4.4 Saudi Arabia AI In Cancer Diagnostics Market
    - 7.4.4.4.1 Saudi Arabia AI In Cancer Diagnostics Market by End-user
    - 7.4.4.4.2 Saudi Arabia AI In Cancer Diagnostics Market by Component
    - 7.4.4.4.3 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.4.5 South Africa AI In Cancer Diagnostics Market
    - 7.4.4.5.1 South Africa AI In Cancer Diagnostics Market by End-user
    - 7.4.4.5.2 South Africa AI In Cancer Diagnostics Market by Component
    - 7.4.4.5.3 South Africa AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.4.6 Nigeria AI In Cancer Diagnostics Market
    - 7.4.4.6.1 Nigeria AI In Cancer Diagnostics Market by End-user
    - 7.4.4.6.2 Nigeria AI In Cancer Diagnostics Market by Component
    - 7.4.4.6.3 Nigeria AI In Cancer Diagnostics Market by Cancer Type
  - 7.4.4.7 Rest of LAMEA AI In Cancer Diagnostics Market
    - 7.4.4.7.1 Rest of LAMEA AI In Cancer Diagnostics Market by End-user
    - 7.4.4.7.2 Rest of LAMEA AI In Cancer Diagnostics Market by Component
    - 7.4.4.7.3 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type

Chapter 8. Company Profiles

8.1 Microsoft Corporation
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Paige AI, Inc.
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
  - 8.3.2.1 Partnerships, Collaborations, and Agreements:
  - 8.3.2.2 Product Launches and Product Expansions:
8.4 PathAI, Inc.
- 8.4.1 Company Overview
- 8.4.2 Recent strategies and developments:
  - 8.4.2.1 Partnerships, Collaborations, and Agreements:
  - 8.4.2.2 Acquisition and Mergers:
8.5 Therapixel
- 8.5.1 Company Overview
- 8.5.2 Recent strategies and developments:
  - 8.5.2.1 Product Launches and Product Expansions:
8.6 Tempus, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
  - 8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 SkinVision BV
- 8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
- 8.8.1 Company Overview
8.9 Medial EarlySign
- 8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
  - 8.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

TABLE 1 Global AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 2 Global AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
TABLE 6 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 7 Global AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 8 Global Hospital Market by Region, 2018 - 2021, USD Thousands
TABLE 9 Global Hospital Market by Region, 2022 - 2028, USD Thousands
TABLE 10 Global Surgical Centers & Medical Institutes Market by Region, 2018 - 2021, USD Thousands
TABLE 11 Global Surgical Centers & Medical Institutes Market by Region, 2022 - 2028, USD Thousands
TABLE 12 Global Others Market by Region, 2018 - 2021, USD Thousands
TABLE 13 Global Others Market by Region, 2022 - 2028, USD Thousands
TABLE 14 Global AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 15 Global AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 16 Global Software Solutions Market by Region, 2018 - 2021, USD Thousands
TABLE 17 Global Software Solutions Market by Region, 2022 - 2028, USD Thousands
TABLE 18 Global Hardware Market by Region, 2018 - 2021, USD Thousands
TABLE 19 Global Hardware Market by Region, 2022 - 2028, USD Thousands
TABLE 20 Global Services Market by Region, 2018 - 2021, USD Thousands
TABLE 21 Global Services Market by Region, 2022 - 2028, USD Thousands
TABLE 22 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 23 Global AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 24 Global Breast Cancer Market by Region, 2018 - 2021, USD Thousands
TABLE 25 Global Breast Cancer Market by Region, 2022 - 2028, USD Thousands
TABLE 26 Global Lung Cancer Market by Region, 2018 - 2021, USD Thousands
TABLE 27 Global Lung Cancer Market by Region, 2022 - 2028, USD Thousands
TABLE 28 Global Brain Tumor Market by Region, 2018 - 2021, USD Thousands
TABLE 29 Global Brain Tumor Market by Region, 2022 - 2028, USD Thousands
TABLE 30 Global Skin Cancer & Cervical Cancer Market by Region, 2018 - 2021, USD Thousands
TABLE 31 Global Skin Cancer & Cervical Cancer Market by Region, 2022 - 2028, USD Thousands
TABLE 32 Global Prostate & Colorectal Cancer Market by Region, 2018 - 2021, USD Thousands
TABLE 33 Global Prostate & Colorectal Cancer Market by Region, 2022 - 2028, USD Thousands
TABLE 34 Global Others Market by Region, 2018 - 2021, USD Thousands
TABLE 35 Global Others Market by Region, 2022 - 2028, USD Thousands
TABLE 36 Global AI In Cancer Diagnostics Market by Region, 2018 - 2021, USD Thousands
TABLE 37 Global AI In Cancer Diagnostics Market by Region, 2022 - 2028, USD Thousands
TABLE 38 North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 39 North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 40 North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 41 North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 42 North America Hospital Market by Country, 2018 - 2021, USD Thousands
TABLE 43 North America Hospital Market by Country, 2022 - 2028, USD Thousands
TABLE 44 North America Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
TABLE 45 North America Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
TABLE 46 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 47 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 48 North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 49 North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 50 North America Software Solutions Market by Country, 2018 - 2021, USD Thousands
TABLE 51 North America Software Solutions Market by Country, 2022 - 2028, USD Thousands
TABLE 52 North America Hardware Market by Country, 2018 - 2021, USD Thousands
TABLE 53 North America Hardware Market by Country, 2022 - 2028, USD Thousands
TABLE 54 North America Services Market by Country, 2018 - 2021, USD Thousands
TABLE 55 North America Services Market by Country, 2022 - 2028, USD Thousands
TABLE 56 North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 57 North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 58 North America Breast Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 59 North America Breast Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 60 North America Lung Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 61 North America Lung Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 62 North America Brain Tumor Market by Country, 2018 - 2021, USD Thousands
TABLE 63 North America Brain Tumor Market by Country, 2022 - 2028, USD Thousands
TABLE 64 North America Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 65 North America Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 66 North America Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 67 North America Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 68 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 69 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 70 North America AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 71 North America AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 72 US AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 73 US AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 74 US AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 75 US AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 76 US AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 77 US AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 78 US AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 79 US AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 80 Canada AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 81 Canada AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 82 Canada AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 83 Canada AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 84 Canada AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 85 Canada AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 86 Canada AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 87 Canada AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 88 Mexico AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 89 Mexico AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 90 Mexico AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 91 Mexico AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 92 Mexico AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 93 Mexico AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 94 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 95 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 96 Rest of North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 97 Rest of North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 98 Rest of North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 99 Rest of North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 100 Rest of North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 101 Rest of North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 102 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 103 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 104 Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 105 Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 106 Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 107 Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 108 Europe Hospital Market by Country, 2018 - 2021, USD Thousands
TABLE 109 Europe Hospital Market by Country, 2022 - 2028, USD Thousands
TABLE 110 Europe Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
TABLE 111 Europe Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
TABLE 112 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 113 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 114 Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 115 Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 116 Europe Software Solutions Market by Country, 2018 - 2021, USD Thousands
TABLE 117 Europe Software Solutions Market by Country, 2022 - 2028, USD Thousands
TABLE 118 Europe Hardware Market by Country, 2018 - 2021, USD Thousands
TABLE 119 Europe Hardware Market by Country, 2022 - 2028, USD Thousands
TABLE 120 Europe Services Market by Country, 2018 - 2021, USD Thousands
TABLE 121 Europe Services Market by Country, 2022 - 2028, USD Thousands
TABLE 122 Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 123 Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 124 Europe Breast Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 125 Europe Breast Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 126 Europe Lung Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 127 Europe Lung Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 128 Europe Brain Tumor Market by Country, 2018 - 2021, USD Thousands
TABLE 129 Europe Brain Tumor Market by Country, 2022 - 2028, USD Thousands
TABLE 130 Europe Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 131 Europe Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 132 Europe Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 133 Europe Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 134 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 135 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 136 Europe AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 137 Europe AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 138 Germany AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 139 Germany AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 140 Germany AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 141 Germany AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 142 Germany AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 143 Germany AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 144 Germany AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 145 Germany AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 146 UK AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 147 UK AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 148 UK AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 149 UK AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 150 UK AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 151 UK AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 152 UK AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 153 UK AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 154 France AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 155 France AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 156 France AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 157 France AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 158 France AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 159 France AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 160 France AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 161 France AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 162 Russia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 163 Russia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 164 Russia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 165 Russia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 166 Russia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 167 Russia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 168 Russia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 169 Russia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 170 Spain AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 171 Spain AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 172 Spain AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 173 Spain AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 174 Spain AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 175 Spain AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 176 Spain AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 177 Spain AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 178 Italy AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 179 Italy AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 180 Italy AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 181 Italy AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 182 Italy AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 183 Italy AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 184 Italy AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 185 Italy AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 186 Rest of Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 187 Rest of Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 188 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 189 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 190 Rest of Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 191 Rest of Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 192 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 193 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 194 Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 195 Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 196 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 197 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 198 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Thousands
TABLE 199 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Thousands
TABLE 200 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
TABLE 201 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
TABLE 202 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 203 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 204 Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 205 Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 206 Asia Pacific Software Solutions Market by Country, 2018 - 2021, USD Thousands
TABLE 207 Asia Pacific Software Solutions Market by Country, 2022 - 2028, USD Thousands
TABLE 208 Asia Pacific Hardware Market by Country, 2018 - 2021, USD Thousands
TABLE 209 Asia Pacific Hardware Market by Country, 2022 - 2028, USD Thousands
TABLE 210 Asia Pacific Services Market by Country, 2018 - 2021, USD Thousands
TABLE 211 Asia Pacific Services Market by Country, 2022 - 2028, USD Thousands
TABLE 212 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 213 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 214 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 215 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 216 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 217 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 218 Asia Pacific Brain Tumor Market by Country, 2018 - 2021, USD Thousands
TABLE 219 Asia Pacific Brain Tumor Market by Country, 2022 - 2028, USD Thousands
TABLE 220 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 221 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 222 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 223 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 224 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 225 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 226 Asia Pacific AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 227 Asia Pacific AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 228 China AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 229 China AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 230 China AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 231 China AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 232 China AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 233 China AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 234 China AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 235 China AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 236 Japan AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 237 Japan AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 238 Japan AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 239 Japan AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 240 Japan AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 241 Japan AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 242 Japan AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 243 Japan AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 244 India AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 245 India AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 246 India AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 247 India AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 248 India AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 249 India AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 250 India AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 251 India AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 252 South Korea AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 253 South Korea AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 254 South Korea AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 255 South Korea AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 256 South Korea AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 257 South Korea AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 258 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 259 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 260 Singapore AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 261 Singapore AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 262 Singapore AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 263 Singapore AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 264 Singapore AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 265 Singapore AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 266 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 267 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 268 Malaysia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 269 Malaysia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 270 Malaysia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 271 Malaysia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 272 Malaysia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 273 Malaysia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 274 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 275 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 276 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 277 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 278 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 279 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 280 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 281 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 282 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 283 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 284 LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 285 LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 286 LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 287 LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 288 LAMEA Hospital Market by Country, 2018 - 2021, USD Thousands
TABLE 289 LAMEA Hospital Market by Country, 2022 - 2028, USD Thousands
TABLE 290 LAMEA Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
TABLE 291 LAMEA Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
TABLE 292 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
TABLE 293 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
TABLE 294 LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 295 LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 296 LAMEA Software Solutions Market by Country, 2018 - 2021, USD Thousands
TABLE 297 LAMEA Software Solutions Market by Country, 2022 - 2028, USD Thousands
TABLE 298 LAMEA Hardware Market by Country, 2018 - 2021, USD Thousands
TABLE 299 LAMEA Hardware Market by Country, 2022 - 2028, USD Thousands
TABLE 300 LAMEA Services Market by Country, 2018 - 2021, USD Thousands
TABLE 301 LAMEA Services Market by Country, 2022 - 2028, USD Thousands
TABLE 302 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 303 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 304 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 305 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 306 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 307 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 308 LAMEA Brain Tumor Market by Country, 2018 - 2021, USD Thousands
TABLE 309 LAMEA Brain Tumor Market by Country, 2022 - 2028, USD Thousands
TABLE 310 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 311 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 312 LAMEA Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 313 LAMEA Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 314 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
TABLE 315 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
TABLE 316 LAMEA AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 317 LAMEA AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands

TABLE 318 Brazil AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 319 Brazil AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 320 Brazil AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 321 Brazil AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 322 Brazil AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 323 Brazil AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 324 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 325 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 326 Argentina AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 327 Argentina AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 328 Argentina AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 329 Argentina AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 330 Argentina AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 331 Argentina AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 332 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 333 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 334 UAE AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 335 UAE AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 336 UAE AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 337 UAE AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 338 UAE AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 339 UAE AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 340 UAE AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 341 UAE AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 342 Saudi Arabia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 343 Saudi Arabia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 344 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 345 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 346 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 347 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 348 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 349 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 350 South Africa AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 351 South Africa AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 352 South Africa AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 353 South Africa AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 354 South Africa AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 355 South Africa AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 356 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 357 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 358 Nigeria AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 359 Nigeria AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 360 Nigeria AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 361 Nigeria AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 362 Nigeria AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 363 Nigeria AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 364 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 365 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 366 Rest of LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 367 Rest of LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 368 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 369 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 370 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 371 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 372 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 373 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 374 key information - Microsoft Corporation
TABLE 375 Key Information - Flatiron Health
TABLE 376 Key Information -Paige AI, Inc.
TABLE 377 Key Information - PathAI, Inc.
TABLE 378 Key Information -Therapixel
TABLE 379 Key Information - Tempus, Inc.
TABLE 380 Key Information - SkinVision BV
TABLE 381 Key Information - Cancer Center Sp. z o.o.
TABLE 382 Key Information - Medial EarlySign
TABLE 383 Key Information - Kheiron Medical Technologies Limited

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
FIG 5 Global AI In Cancer Diagnostics Market Share by End-user, 2021
FIG 6 Global AI In Cancer Diagnostics Market Share by End-user, 2028
FIG 7 Global AI In Cancer Diagnostics Market by End-user, 2018 - 2028, USD Thousands
FIG 8 Global AI In Cancer Diagnostics Market Share by Component, 2021
FIG 9 Global AI In Cancer Diagnostics Market Share by Component, 2028
FIG 10 Global AI In Cancer Diagnostics Market by Component, 2018 - 2028, USD Thousands
FIG 11 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2021
FIG 12 Global AI In Cancer Diagnostics Market Share by Cancer Type, 2028
FIG 13 Global AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2028, USD Thousands
FIG 14 Global AI In Cancer Diagnostics Market Share by Region, 2021
FIG 15 Global AI In Cancer Diagnostics Market Share by Region, 2028
FIG 16 Global AI In Cancer Diagnostics Market by Region, 2018 - 2028, USD Thousands
FIG 17 SWOT Analysis: Microsoft Corporation
FIG 18 Recent strategies and developments: Paige AI, Inc.
FIG 19 Recent strategies and developments: PathAI, Inc.

Global AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Regional Outlook and Forecast, 2022 - 2028

Description

Table of Contents